Ontology highlight
ABSTRACT: Rationale
Metabotropic glutamate receptors and muscarinic M4 receptors have been proposed as novel targets for various brain disorders, including schizophrenia. Both receptors are coupled to Go/i proteins and are expressed in brain circuits that are important in schizophrenia. Therefore, their mutual activation may be an effective treatment and allow minimizing the doses of ligands required for optimal activity.Objectives
In the present studies, subactive doses of mGlu4 and M4 activators (LSP4-2022 and VU152100, respectively) were administered to investigate the mutual interaction between mGlu4 and M4 receptors in animal models of schizophrenia.Methods
The behavioral tests used were MK-801-induced hyp
SUBMITTER: Cieslik P
PROVIDER: S-EPMC6182605 | biostudies-literature | 2018 Oct
REPOSITORIES: biostudies-literature